Zobrazeno 1 - 10
of 311
pro vyhledávání: ''
Autor:
Akile Zengin, Fatih Sumer, Yusuf Murat Bag, Cuneyt Kayaalp, Kuntay Kaplan, Huseyin Kocaaslan, Mehmet Can Aydin
Publikováno v:
Nutrition and Cancer. 74:2088-2094
Gastic cancer is a life-threatening malignancy in the world. The aim of this study was to investigate the clinical significance of the prognostic nutritional index (PNI) as a guiding marker for gastric cancer patients with laparoscopic gastrectomy. W
Publikováno v:
Leuk Lymphoma
Relapsed/refractory Primary Central Nervous System Lymphoma (R/R PCNSL) has a poor prognosis with no established preferred treatment. We report the efficacy and toxicity of a combination chemotherapy regimen: methotrexate, carmustine, etoposide, and
Publikováno v:
Cancer Investigation. 40:124-131
BACKGROUND Large Cell Neuroendocrine Carcinoma of the Lung (L-LCNEC) is a rare type of neuroendocrine lung cancer that is increasingly diagnosed. However, the optimal management regarding the advanced stage is unclear. The purpose of this article is
Publikováno v:
Leukemia & Lymphoma. 63:131-141
To describe patient characteristics, treatment patterns, and survival among elderly patients (≥66 years) newly diagnosed with acute myeloid leukemia (AML) meeting ≥1 ineligibility criteria for high-intensity chemotherapy (HIC; i.e. age >75 years,
Autor:
Shun Matsuura, Koshiro Ichijo, Yutaro Ito, Norimichi Akiyama, Tsutomu Kubota, Eisuke Mochizuki, Naoki Koshimizu, Masahiro Uehara, Keisuke Morikawa, Masanori Harada, Masaru Tsukui
Publikováno v:
Nutrition and Cancer. 74:1606-1613
We aimed to assess the prognostic and predictive significance of pretreatment Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) measurements on advanced non-small cell lung cancer (NSCLC) patients treated with first-line
Publikováno v:
Cancer Biol Ther
Circulating tumor DNA (ctDNA) is utilized for molecular profiling of cancers, and is under investigation for a growing number of applications based on the assumption that ctDNA levels faithfully reflect disease burden. Our objective was to investigat
Autor:
David Dingli, Eli Muchtar, Taxiarchis Kourelis, Alissa Visram, Abdullah S. Al Saleh, Ronald S. Go, Martha Q. Lacy, Francis K. Buadi, Shaji Kumar, Harsh Parmar, Prashant Kapoor, S. Vincent Rajkumar, Morie A. Gertz, Robert A. Kyle, Rahma Warsame, Suzanne R. Hayman, Nelson Leung, Angela Dispenzieri, Wilson I. Gonsalves
Publikováno v:
Leukemia & Lymphoma. 62:3011-3018
This is a retrospective study of patients with multiple myeloma (MM) who were >75 years old. We identified 394 patients and for non-trial patients (n = 350), immunomodulatory drug (IMiD)+dex (32%) was the most commonly used regimen followed by alkyla
Autor:
Jianhua Feng, Kang Yu, Yisha Huang, Qianying Zhang, Yu Zhang, Yiyun Feng, Kanchun Dai, Deeksha Bhardwaj
Publikováno v:
Cancer Investigation. 39:550-558
This study aimed to examine the prognostic significance of peripheral absolute monocyte count (AMC) in combination with absolute lymphocyte count (ALC) at the time of relapse in a cohort of 57 patients with early relapsed (first complete remission12
Publikováno v:
Leukemia & Lymphoma. 62:2785-2792
About 20% of MM patients have T2DM. We assessed the impact of T2DM/pre-T2DM on MM progression and OS. We collected retrospective data of newly diagnosed MM patients in Maccabi health services, Israel, between 2012 and 2016. The study included 503 MM
Autor:
Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
Publikováno v:
Cancer Investigation. 39:473-481
Aim: The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment. Method: Retrospective analysis of T-DM1 results of human epidermal grow